HR 5462
107th Congress
House
Health
Administrative procedure
Blood diseases
Cardiovascular diseases
Child health
Congress
Congressional reporting requirements
Cost effectiveness
Department of Health and Human Services
Diabetes
Economics and Public Finance
Executive reorganization
Families
Federal advisory bodies
Federal aid to medical research
Finance and Financial Sector
Government Operations and Politics
Governmental investigations
Insulin
Labor and Employment
Pancreatic Islet Cell Transplantation Act of 2002
Introduced: September 25, 2002
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 8, 2002
Referred to the Subcommittee on Health.
Sep 26, 2002
Sponsor introductory remarks on measure. (CR E1660)
Sep 25, 2002
Referred to the House Committee on Energy and Commerce.
Sep 25, 2002
Introduced in House
Plain-English summary
Pancreatic Islet Cell Transplantation Act of 2002 - Amends the Public Health Service Act to include pancreases procured by an organ procurement organization and used for islet cell transplantation or research to be counted toward organ procurement organization certification.
Establishes the Interagency Committee on Islet Cell Transplantation within the Department of Health and Human Services (HHS). Requires the Committee to study related issues, including Federal research funding, the effect of specified policies on transplantation, and data collection.
Instructs the Secretary of HHS to request the Institute of Medicine to provide a study of the impact of islet cell transplantation on juvenile diabetes patients, including their health and the treatment's cost-effectiveness.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2